{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:46:06Z","timestamp":1782715566866,"version":"3.54.5"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science and Technology Council, Taiwan","award":["NSTC 113- 2320-B-182-026-MY3"],"award-info":[{"award-number":["NSTC 113- 2320-B-182-026-MY3"]}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC 114-2314-B-038-061"],"award-info":[{"award-number":["NSTC 114-2314-B-038-061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11064-026-04761-3","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:09:14Z","timestamp":1777262954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FTDP-17T Mutations Promote Formation of Phosphorylated FTDP-17T TAU Oligomers That Cause Degeneration of Dopaminergic and Hippocampal Neurons via Activating ER Stress and Mitochondrial Pro-apoptotic Cascades"],"prefix":"10.1007","volume":"51","author":[{"given":"Hung-Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Shia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu-Hsueh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"4761_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:5\u201321","journal-title":"Nat Rev Neurosci"},{"key":"4761_CR2","doi-asserted-by":"publisher","first-page":"15383","DOI":"10.3390\/ijms232315383","volume":"23","author":"A Corsi","year":"2022","unstructured":"Corsi A, Bombieri C, Valenti MT, Romanelli MG (2022) Tau isoforms: gaining insight into MAPT alternative splicing. Int J Mol Sci 23:15383","journal-title":"Int J Mol Sci"},{"key":"4761_CR3","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1007\/s12035-023-03387-8","volume":"60","author":"Z Waheed","year":"2023","unstructured":"Waheed Z, Choudhary J, Jatala FH, Fatimah, Noor A, Zerr I, Zafar S (2023) The role of Tau proteoforms in health and disease. Mol Neurobiol 60:5155\u20135166","journal-title":"Mol Neurobiol"},{"key":"4761_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","volume":"25","author":"CP Bravo","year":"2024","unstructured":"Bravo CP, Naguib SA, Gan L (2024) Cellular and pathological functions of tau. Nat Rev Mol Cell Biol 25:845\u2013864","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4761_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12031-011-9568-5","volume":"45","author":"S Fujioka","year":"2011","unstructured":"Fujioka S, Wszolek ZK (2011) Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism. J Mol Neurosci 45:359\u2013365","journal-title":"J Mol Neurosci"},{"key":"4761_CR6","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","volume":"99","author":"KH Strang","year":"2019","unstructured":"Strang KH, Golde TE, Giasson BI (2019) MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab Invest 99:912\u2013928","journal-title":"Lab Invest"},{"key":"4761_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/cm.21812","volume":"81","author":"M Goedert","year":"2024","unstructured":"Goedert M, Crowther RA, Scheres SHW, Spillantini MG (2024) Tau and neurodegeneration. Cytoskeleton 81:95\u2013102","journal-title":"Cytoskeleton"},{"key":"4761_CR8","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916\u2013919","journal-title":"Nature"},{"key":"4761_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nature05017","volume":"442","author":"M Cruts","year":"2006","unstructured":"Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D et al (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442:920\u2013924","journal-title":"Nature"},{"key":"4761_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","volume":"14","author":"J G\u00f6tz","year":"2019","unstructured":"G\u00f6tz J, Halliday G, Nisbet RM (2019) Molecular pathogenesis of the tauopathies. Annu Rev Pathol 14:239\u2013261","journal-title":"Annu Rev Pathol"},{"key":"4761_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00476-x","volume":"16","author":"DEC Chung","year":"2021","unstructured":"Chung DEC, Roemer S, Petrucelli L, Dickson DW (2021) Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener 16:57","journal-title":"Mol Neurodegener"},{"key":"4761_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.595532","volume":"11","author":"C Alquezar","year":"2021","unstructured":"Alquezar C, Arya S, Kao AW (2021) Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation. Front Neurol 11:595532","journal-title":"Front Neurol"},{"key":"4761_CR13","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s12031-022-02002-0","volume":"72","author":"H Ye","year":"2022","unstructured":"Ye H, Han Y, Li P, Su Z, Huang Y (2022) The role of post-translational modifications on the structure and function of tau protein. J Mol Neurosci 72:1557\u20131571","journal-title":"J Mol Neurosci"},{"key":"4761_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/cells10040721","volume":"10","author":"CL Sayas","year":"2021","unstructured":"Sayas CL, \u00c1vila J (2021) GSK-3 and Tau: a key duet in Alzheimer\u2019s disease. Cells 10:721","journal-title":"Cells"},{"key":"4761_CR15","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1007\/s12035-022-02809-3","volume":"59","author":"SY Liang","year":"2022","unstructured":"Liang SY, Wang ZT, Tan L, Yu JT (2022) Tau toxicity in neurodegeneration. Mol Neurobiol 59:3617\u20133634","journal-title":"Mol Neurobiol"},{"key":"4761_CR16","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1046\/j.1471-4159.2003.02287.x","volume":"88","author":"C Haase","year":"2004","unstructured":"Haase C, Stieler JT, Arendt T, Holzer M (2004) Pseudophosphorylation of tau protein alters its ability for self-aggregation. J Neurochem 88:1509\u20131520","journal-title":"J Neurochem"},{"key":"4761_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2316175121","volume":"121","author":"N El Mammeri","year":"2024","unstructured":"El Mammeri N, Dregni AJ, Duan P, Hong M (2024) Structures of AT8 and PHF1 phosphomimetic tau: insights into the posttranslational modification code of tau aggregation. Proc Natl Acad Sci USA 121:e2316175121","journal-title":"Proc Natl Acad Sci USA"},{"key":"4761_CR18","doi-asserted-by":"publisher","first-page":"34873","DOI":"10.1074\/jbc.M405131200","volume":"279","author":"AD Alonso","year":"2004","unstructured":"Alonso AD, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K (2004) Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem 279:34873\u201334881","journal-title":"J Biol Chem"},{"key":"4761_CR19","doi-asserted-by":"publisher","first-page":"S507","DOI":"10.3233\/JAD-179906","volume":"64","author":"AD Alonso","year":"2018","unstructured":"Alonso AD, Cohen LS (2018) Our tau tales from normal to pathological behavior. J Alzheimers Dis 64:S507\u2013S516","journal-title":"J Alzheimers Dis"},{"key":"4761_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115923","volume":"218","author":"C Wang","year":"2023","unstructured":"Wang C, Cui Y, Xu T, Zhou Y, Yang R, Wang T (2023) New insights into glycogen synthase kinase-3: a common target for neurodegenerative diseases. Biochem Pharmacol 218:115923","journal-title":"Biochem Pharmacol"},{"key":"4761_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1209703","volume":"16","author":"H Yu","year":"2023","unstructured":"Yu H, Min X, Zhang Z (2023) The role of glycogen synthase kinase 3 beta in neurodegenerative diseases. Front Mol Neurosci 16:1209703","journal-title":"Front Mol Neurosci"},{"key":"4761_CR22","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1007\/s12035-024-04003-z","volume":"61","author":"A Turkistani","year":"2024","unstructured":"Turkistani A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M et al (2024) Therapeutic potential effect of glycogen synthase kinase 3 beta (GSK-3\u03b2) inhibitors in Parkinson disease: exploring an overlooked avenue. Mol Neurobiol 61:7092\u20137108","journal-title":"Mol Neurobiol"},{"key":"4761_CR23","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1007\/s12035-023-03839-1","volume":"61","author":"RC Sequeira","year":"2024","unstructured":"Sequeira RC, Godad A (2024) Understanding glycogen synthase kinase-3: a novel avenue for Alzheimer\u2019s disease. Mol Neurobiol 61:4203\u20134221","journal-title":"Mol Neurobiol"},{"key":"4761_CR24","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1007\/s12035-020-02034-w","volume":"57","author":"M Liu","year":"2020","unstructured":"Liu M, Sui D, Dexheimer T, Hovde S, Deng X, Wang KW et al (2020) Hyperphosphorylation renders tau prone to aggregate and to cause cell death. Mol Neurobiol 57:4704\u20134719","journal-title":"Mol Neurobiol"},{"key":"4761_CR25","doi-asserted-by":"publisher","first-page":"e2414176121","DOI":"10.1073\/pnas.2414176121","volume":"121","author":"P Chakraborty","year":"2024","unstructured":"Chakraborty P, de Opakua AI, Purslow JA, Fromm SA, Chatterjee D, Zachrdla M et al (2024) GSK3\u03b2 phosphorylation catalyzes the aggregation of tau into Alzheimer\u2019s disease-like filaments. Proc Natl Acad Sci USA 121:e2414176121","journal-title":"Proc Natl Acad Sci USA"},{"key":"4761_CR26","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1038\/s41467-019-10355-1","volume":"10","author":"D Chen","year":"2019","unstructured":"Chen D, Drombosky KW, Hou Z, Sari L, Kashmer OM, Ryder BD et al (2019) Tau local structure shields an amyloid-forming motif and controls aggregation propensity. Na Commun 10:2493\u20132514","journal-title":"Na Commun"},{"key":"4761_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1021\/jacsau.3c00550","volume":"4","author":"K Pounot","year":"2023","unstructured":"Pounot K, Piersson C, Goring AK, Rosu F, Gabelica V, Weik M et al (2023) Mutations in tau protein promote aggregation by favoring extended conformations. JACS Au 4:92\u2013100","journal-title":"JACS Au"},{"key":"4761_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ (2020) Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol 21:421\u2013436","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4761_CR29","doi-asserted-by":"publisher","first-page":"15186","DOI":"10.3390\/ijms232315186","volume":"23","author":"A Merighi","year":"2022","unstructured":"Merighi A, Lossi L (2022) Endoplasmic reticulum stress signaling and neuronal cell death. Int J Mol Sci 23:15186","journal-title":"Int J Mol Sci"},{"key":"4761_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121983","volume":"330","author":"P Nagar","year":"2023","unstructured":"Nagar P, Sharma P, Dhapola R, Kumari S, Medhi B, HariKrishnaReddy D (2023) Endoplasmic reticulum stress in Alzheimer\u2019s disease: molecular mechanisms and therapeutic prospects. Life Sci 330:121983","journal-title":"Life Sci"},{"key":"4761_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1288894","volume":"14","author":"D Wang","year":"2023","unstructured":"Wang D, Qu S, Zhang Z, Tan L, Chen X, Zhong HJ et al (2023) Strategies targeting endoplasmic reticulum stress to improve Parkinson\u2019s disease. Front Pharmacol 14:1288894","journal-title":"Front Pharmacol"},{"key":"4761_CR32","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.bbamcr.2015.03.003","volume":"1853","author":"Z Tang","year":"2015","unstructured":"Tang Z, Ioja E, Bereczki E, Hultenby K, Li C, Guan Z et al (2015) mTor mediates tau localization and secretion: implication for Alzheimer\u2019s disease. Biochim Biophys Acta 1853:1646\u20131657","journal-title":"Biochim Biophys Acta"},{"key":"4761_CR33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3233\/JAD-150298","volume":"48","author":"S Meier","year":"2015","unstructured":"Meier S, Bell M, Lyons DN, Ingram A, Chen J, Gensel JC et al (2015) Identification of novel tau interactions with endoplasmic reticulum proteins in Alzheimer\u2019s disease brain. J Alzheimers Dis 48:687\u2013702","journal-title":"J Alzheimers Dis"},{"key":"4761_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/JAD-181021","volume":"68","author":"NI Bocai","year":"2019","unstructured":"Bocai NI, Marcora MS, Belfiori-Carrasco LF, Morelli L, Casta\u00f1o EM (2019) Endoplasmic reticulum stress in tauopathies: contrasting human brain pathology with cellular and animal models. J Alzheimers Dis 68:439\u2013458","journal-title":"J Alzheimers Dis"},{"key":"4761_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01791-8","volume":"22","author":"O Kosz\u0142a","year":"2024","unstructured":"Kosz\u0142a O, So\u0142ek P (2024) Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways. Cell Commun Signal 22:421","journal-title":"Cell Commun Signal"},{"key":"4761_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B (2024) Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics 21:e00292","journal-title":"Neurotherapeutics"},{"key":"4761_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020327","volume":"13","author":"K Meng","year":"2025","unstructured":"Meng K, Jia H, Hou X, Zhu Z, Lu Y, Feng Y et al (2025) Mitochondrial dysfunction in neurodegenerative diseases: mechanisms and corresponding therapeutic strategies. Biomedicines 13:327","journal-title":"Biomedicines"},{"key":"4761_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102713","volume":"107","author":"MCB D\u2019Alessandro","year":"2025","unstructured":"D\u2019Alessandro MCB, Kanaan S, Geller M, Pratic\u00f2 D, Daher JPL (2025) Mitochondrial dysfunction in Alzheimer\u2019s disease. Ageing Res Rev 107:102713","journal-title":"Ageing Res Rev"},{"key":"4761_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF (2023) Mitochondrial dysfunction in Parkinson\u2019s disease - a key disease hallmark with therapeutic potential. Mol Neurodegener 18:83","journal-title":"Mol Neurodegener"},{"key":"4761_CR40","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.3390\/ijms21176344","volume":"21","author":"L Szabo","year":"2020","unstructured":"Szabo L, Eckert A, Grimm A (2020) Insights into disease-associated tau impact on mitochondria. Int J Mol Sci 21:6344","journal-title":"Int J Mol Sci"},{"key":"4761_CR41","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","volume":"185","author":"TE Tracy","year":"2022","unstructured":"Tracy TE, Madero-P\u00e9rez J, Swaney DL, Chang TS, Moritz M, Konrad C et al (2022) Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell 185:712\u2013728","journal-title":"Cell"},{"key":"4761_CR42","doi-asserted-by":"publisher","first-page":"167204","DOI":"10.1016\/j.bbadis.2024.167204","volume":"1870","author":"Y Rabanal-Ruiz","year":"2024","unstructured":"Rabanal-Ruiz Y, Pedrero-Prieto CM, Sanchez-Rodriguez L, Flores-Cuadrado A, Saiz-Sanchez D, Frontinan-Rubio J et al (2024) Differential accumulation of human \u03b2-amyloid and tau from enriched extracts in neuronal and endothelial cells. Biochim Biophys Acta Mol Basis Dis 1870:167204","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4761_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.765408","volume":"9","author":"V Bharat","year":"2021","unstructured":"Bharat V, Hsieh CH, Wang X (2021) Mitochondrial defects in fibroblasts of pathogenic MAPT patients. Front Cell Dev Biol 9:765408","journal-title":"Front Cell Dev Biol"},{"key":"4761_CR44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s40001-025-02699-w","volume":"30","author":"X Li","year":"2025","unstructured":"Li X, Wu Z, Si X, Li J, Wu G, Wang M (2025) The role of mitochondrial dysfunction in the pathogenesis of Alzheimer\u2019s disease and future strategies for targeted therapy. Eur J Med Res 30:434","journal-title":"Eur J Med Res"},{"key":"4761_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0966-3","volume":"17","author":"HC Lin","year":"2017","unstructured":"Lin HC, Lin CH, Chen PL, Cheng SJ, Chen PH (2017) Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: a case report and literature review. BMC Neurol 17:186","journal-title":"BMC Neurol"},{"key":"4761_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3233\/JAD-130413","volume":"37","author":"MP Chaunu","year":"2013","unstructured":"Chaunu MP, Deramecourt V, Bu\u00e9e-Scherrer V, Le Ber I, Brice A, Ehrle N, El Hachimi K, Pluot M, Maurage C, Bakchine S, Bu\u00e9e L (2013) Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R. J Alzheimers Dis 37:769\u2013776","journal-title":"J Alzheimers Dis"},{"key":"4761_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1440-1789.2006.00742.x","volume":"27","author":"J Slowinski","year":"2007","unstructured":"Slowinski J, Dominik J, Uitti RJ, Ahmed Z, Dickson DD, Wszolek ZK (2007) Frontotemporal dementia and Parkinsonism linked to chromosome 17 with the N279K tau mutation. Neuropathology 27:73\u201380","journal-title":"Neuropathology"},{"key":"4761_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00401-013-1219-1","volume":"127","author":"M Iovino","year":"2014","unstructured":"Iovino M, Pfisterer U, Holton JL, Lashley T, Swingler RJ, Calo L et al (2014) The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons. Acta Neuropathol 127:283\u2013295","journal-title":"Acta Neuropathol"},{"key":"4761_CR49","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/ana.20668","volume":"58","author":"M Yasuda","year":"2005","unstructured":"Yasuda M, Nakamura Y, Kawamata T, Kaneyuki H, Maeda K, Komure O (2005) Phenotypic heterogeneity within a new family with the MAPT p301s mutation. Ann Neurol 58:920\u2013928","journal-title":"Ann Neurol"},{"key":"4761_CR50","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1212\/01.WNL.0000160116.65034.12","volume":"64","author":"JJ Zarranz","year":"2005","unstructured":"Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atar\u00e9s B et al (2005) A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64:1578\u20131585","journal-title":"Neurology"},{"key":"4761_CR51","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1007\/s12035-023-03830-w","volume":"61","author":"Y Shen","year":"2024","unstructured":"Shen Y, Wang X, Nan N, Fu X, Zeng R, Yang Y et al (2024) SIRT3-mediated deacetylation of SDHA rescues mitochondrial bioenergetics contributing to neuroprotection in rotenone-induced PD models. Mol Neurobiol 61:4402\u20134420","journal-title":"Mol Neurobiol"},{"key":"4761_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuroscience.2024.10.033","volume":"562","author":"X Liang","year":"2024","unstructured":"Liang X, Wen Y, Feng C, Xu L, Xian Y, Xie H et al (2024) Neuroglobin protects dopaminergic neurons in a Parkinson\u2019s cell model by interacting with mitochondrial complex NDUFA10. Neuroscience 562:43\u201353","journal-title":"Neuroscience"},{"key":"4761_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1062650","volume":"13","author":"J Lim","year":"2023","unstructured":"Lim J, Bang Y, Kim KM, Choi HJ (2023) Differentiated HT22 cells as a novel model for in vitro screening of serotonin reuptake inhibitors. Front Pharmacol 13:1062650","journal-title":"Front Pharmacol"},{"key":"4761_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115218","volume":"388","author":"A Wang","year":"2025","unstructured":"Wang A, Zhang F, Zhang W, Gong J, Sun X (2025) PPM1D ameliorates Alzheimer\u2019s disease by promoting mitophagy. Exp Neurol 388:115218","journal-title":"Exp Neurol"},{"key":"4761_CR55","doi-asserted-by":"publisher","first-page":"43277","DOI":"10.1074\/jbc.M107013200","volume":"276","author":"DS Castro","year":"2001","unstructured":"Castro DS, Hermanson E, Joseph B, Wall\u00e9n A, Aarnisalo P, Heller A et al (2001) Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. J Biol Chem 276:43277\u201343284","journal-title":"J Biol Chem"},{"key":"4761_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123789","volume":"337","author":"CC Chiu","year":"2025","unstructured":"Chiu CC, Weng YH, Yeh TH, Chen WS, Liu SY, Chiu TJ et al (2025) Absence of Rab39b-induced macroautophagy impairment increases neurotoxic \u03b1-synuclein and causes degeneration of substantia nigra dopaminergic neurons in mouse model of X-linked Parkinson\u2019s disease. Life Sci 337:123789","journal-title":"Life Sci"},{"key":"4761_CR57","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s12035-023-03238-6","volume":"60","author":"CC Chiu","year":"2023","unstructured":"Chiu CC, Weng YH, Yeh TH, Lu JC, Chen WS, Li AHR et al (2023) Deficiency of RAB39B activates ER stress-induced pro-apoptotic pathway and causes mitochondrial dysfunction and oxidative stress in dopaminergic neurons by impairing autophagy and upregulating \u03b1-synuclein. Mol Neurobiol 60:2706\u20132728","journal-title":"Mol Neurobiol"},{"key":"4761_CR58","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.3390\/ijms25126711","volume":"25","author":"CC Chiu","year":"2024","unstructured":"Chiu CC, Chen YL, Weng YH, Liu SY, Li AHL, Yeh TH et al (2024) Downregulation of protease cathepsin D and upregulation of pathologic \u03b1-synuclein mediate paucity of DNAJC6-induced degeneration of dopaminergic neurons. Int J Mol Sci 25:6711","journal-title":"Int J Mol Sci"},{"key":"4761_CR59","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41419-018-0471-7","volume":"9","author":"L Wang","year":"2018","unstructured":"Wang L, Hong J, Wu Y, Liu G, Yu W, Chen L (2018) Seipin deficiency in mice causes loss of dopaminergic neurons via aggregation and phosphorylation of \u03b1-synuclein and neuroinflammation. Cell Death Dis 9:440","journal-title":"Cell Death Dis"},{"key":"4761_CR60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nbd.2018.06.015","volume":"118","author":"P Dohare","year":"2018","unstructured":"Dohare P, Cheng B, Ahmed E, Yadala V, Singla P, Thomas S et al (2018) Glycogen synthase kinase-3\u03b2 inhibition enhances myelination in preterm newborns with intraventricular hemorrhage, but not recombinant Wnt3A. Neurobiol Dis 118:22\u201339","journal-title":"Neurobiol Dis"},{"key":"4761_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109765","volume":"242","author":"L Shi","year":"2024","unstructured":"Shi L, Kang S, Choi CY, Noonan BL, Carrica LK, Liang NC et al (2024) Effects of combined exposure to ethanol and delta-9-tetrahydrocannabinol during adolescence on synaptic plasticity in the prefrontal cortex of Long Evans rats. Neuropharmacology 242:109765","journal-title":"Neuropharmacology"},{"key":"4761_CR62","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1007\/s12035-024-04510-z","volume":"62","author":"S Sun","year":"2025","unstructured":"Sun S, Wang Z, Xu X, Ding X, Xu J, Nan X et al (2025) Mechanisms of differential sensitivity to ethanol-induced apoptosis in mouse spinal cord at different developmental stages-Akt\/GSK signaling and BAX. Mol Neurobiol 62:4301\u20134318","journal-title":"Mol Neurobiol"},{"key":"4761_CR63","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuint.2010.11.018","volume":"58","author":"A Ka\u017amierczak","year":"2011","unstructured":"Ka\u017amierczak A, Czapski GA, Adamczyk A, Gajkowska B, Strosznajder JB (2011) A novel mechanism of non-A\u03b2 component of Alzheimer\u2019s disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5). Neurochem Int 58:206\u2013214","journal-title":"Neurochem Int"},{"key":"4761_CR64","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s12035-012-8301-x","volume":"46","author":"RJS Viana","year":"2012","unstructured":"Viana RJS, Nunes AF, Rodrigues CMP (2012) Endoplasmic reticulum enrollment in Alzheimer\u2019s disease. Mol Neurobiol 46:522\u2013534","journal-title":"Mol Neurobiol"},{"key":"4761_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","volume":"10","author":"M Vogler","year":"2025","unstructured":"Vogler M, Braun Y, Smith VM, Westhoff MA, Pereira RS, Pieper NM et al (2025) The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy. Signal Transduct Target Ther 10:91","journal-title":"Signal Transduct Target Ther"},{"key":"4761_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-018-1861-8","volume":"136","author":"DH Paushter","year":"2018","unstructured":"Paushter DH, Du H, Feng T, Hu F (2018) The lysosomal function of progranulin, a guardian against neurodegeneration. Acta Neuropathol 136:1\u201317","journal-title":"Acta Neuropathol"},{"key":"4761_CR67","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-025-00475-8","volume":"14","author":"K Gaweda-Walerych","year":"2025","unstructured":"Gaweda-Walerych K, Aragona V, Lodato S, Sitek EJ, Naro\u017ca\u0144ska Ewa, Buratti E (2025) Progranulin deficiency in the brain: the interplay between neuronal and non-neuronal cells. Transl Neurodegener 14:18","journal-title":"Transl Neurodegener"},{"key":"4761_CR68","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00415-025-13117-w","volume":"272","author":"J Lin","year":"2025","unstructured":"Lin J, Li H, Jiang L, Li J (2025) Novel strategies for targeting tau oligomers in neurodegenerative diseases. J Neurol 272:383","journal-title":"J Neurol"},{"issue":"9","key":"4761_CR69","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/ijms25094969","volume":"25","author":"H Zheng","year":"2024","unstructured":"Zheng H, Sun H, Cai Q, Tai HC (2024) The enigma of tau protein aggregation: mechanistic insights and future challenges. Int J Mol Sci 25(9):4969","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4761_CR70","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-025-02179-x","volume":"10","author":"X Wu","year":"2025","unstructured":"Wu X, Yang Z, Zou J, Gao H, Shao Z, Li C et al (2025) Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery. Signal Transduct Target Ther 10:146","journal-title":"Signal Transduct Target Ther"},{"key":"4761_CR71","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1474-4422(25)00109-7","volume":"24","author":"R Balendra","year":"2025","unstructured":"Balendra R, Sreedharan J, Hallegger M, Luisier R, Lashuel HA, Gregory JM et al (2025) Amyotrophic lateral sclerosis caused by TARDBP mutations: from genetics to TDP-43 proteinopathy. Lancet Neurol 24:456\u2013470","journal-title":"Lancet Neurol"},{"key":"4761_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-025-00839-8","volume":"20","author":"EA Kellett","year":"2025","unstructured":"Kellett EA, Bademosi AT, Walker AK (2025) Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration. Mol Neurodegener 20:53","journal-title":"Mol Neurodegener"},{"issue":"4","key":"4761_CR73","doi-asserted-by":"publisher","first-page":"688","DOI":"10.34172\/apb.2023.071","volume":"13","author":"SR Shri","year":"2023","unstructured":"Shri SR, Manandhar S, Nayak Y, Pai KSR (2023) Role of GSK-3\u03b2 inhibitors: new promises and opportunities for Alzheimer\u2019s disease. Adv Pharm Bull 13(4):688\u2013700","journal-title":"Adv Pharm Bull"},{"key":"4761_CR74","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1074\/jbc.M115.695379","volume":"291","author":"T Nonaka","year":"2016","unstructured":"Nonaka T, Suzuki G, Tanaka Y, Kametani F, Hirai S, Okado H et al (2016) Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1\u03b4 triggers mislocalization and accumulation of TDP-43. J Biol Chem 291:5473\u20135483","journal-title":"J Biol Chem"},{"key":"4761_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61265-y","volume":"10","author":"L Mart\u00ednez-Gonz\u00e1lez","year":"2020","unstructured":"Mart\u00ednez-Gonz\u00e1lez L, Rodr\u00edguez-Cueto C, Cabezudo D, Bartolom\u00e9 F, Andr\u00e9s-Benito P, Ferrer I et al (2020) Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1\u03b4 kinase inhibitor treatment. Sci Rep 10:4449","journal-title":"Sci Rep"},{"key":"4761_CR76","doi-asserted-by":"publisher","first-page":"105548","DOI":"10.1016\/j.nbd.2021.105548","volume":"161","author":"Y Tian","year":"2021","unstructured":"Tian Y, Wang Y, Jablonski AM, Hu Y, Sugam JA, Koglin M et al (2021) Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology. Neurobiol Dis 161:105548","journal-title":"Neurobiol Dis"},{"key":"4761_CR77","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12993-025-00279-w","volume":"21","author":"DD \u00c1lvarez-Luqu\u00edn","year":"2025","unstructured":"\u00c1lvarez-Luqu\u00edn DD, Gonz\u00e1lez-Fern\u00e1ndez RR, Torres-Velasco ME, Ichikawa-Escamilla E, Arce-Sillas A, Mart\u00ednez-Mart\u00ednez E et al (2025) Neurodegeneration models in Parkinson\u2019s disease: cellular and molecular paths to neuron death. Behav Brain Funct 21:14","journal-title":"Behav Brain Funct"},{"key":"4761_CR78","doi-asserted-by":"publisher","first-page":"103980","DOI":"10.1016\/j.scr.2026.103980","volume":"93","author":"T Hirose","year":"2026","unstructured":"Hirose T, Ishikawa KI, Li Y, Oyama G, Hatano T, Hattori N et al (2026) Generation of three hiPSC clones from a frontotemporal dementia (FTD) patient with a heterozygous MAPT mutation p.K298_H299insQ (c.896_897insACA). Stem Cell Res 93:103980","journal-title":"Stem Cell Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04761-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:04:40Z","timestamp":1782713080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04761-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4761"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04761-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"145"}}